Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Global Markets Direct, November 2008, Pages: 55

Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Mexico drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Mexico

Scope

- The report provides drug delivery devices information broken down into detailed categories and segments in Mexico.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the drug delivery devices market in Mexico.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
3 Definitions of Markets Covered in the Report 9
3.1 lrug delivery devices 9
3.2 Inhalation Systems 9
3.2.1 Metered Dose Inhaler 9
3.2.2 Dry powder inhaler 9
3.3 Infusion Systems 9
3.3.1 Infusion pumps 9
3.3.2 Syringe pumps 9
3.3.3 Disposable Infusion sets 10
4 Healthcare Sector Review 11
5 Regulation System 12
5.1 Device Classification 12
5.2 Registration Process 12
5.3 Labeling Requirements 14
5.4 Import Documentation 15
6 Pricing and Reimbursement 16
7 Distribution Structure 17
8 Drug Delivery Devices In Mexico 18
8.1 Drug Delivery Devices Cross Country Comparison (2000-2012) 18
8.2 Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
8.3 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2012 23
8.4 Drug Delivery Devices, Mexico Company share (2006-2007) 26
9 Infusion Systems In Mexico 27
9.1 Infusion Systems Overall Revenue (2000-2012) 27
9.2 Infusion Systems Overall Volume (2000-2012) 29
9.3 Infusion Systems Average Price (2000-2012) 30
9.4 Infusion Systems Distribution Share (2006-2007) 30
9.5 Infusion Systems, Mexico, Company Share (2006-2007) 31
10 Inhalation Systems In Mexico 32
10.1 Inhalation Systems Overall Revenue (2000-2012) 32
10.2 Inhalation Systems Overall Volume (2000-2012) 34
10.3 Inhalation Systems Average Price (2000-2012) 36
10.4 Inhalation Systems Distribution Share (2006-2007) 36
10.5 Inhalation Systems, Mexico, Company Share (2006-2007) 37
11 3M Company Company Profile 38
11.1 Company Overview 38
11.2 Value Chain Analysis 39
11.2.1 Manufacturing 39
11.2.2 Product Development 39
11.2.3 Sales and Marketing 40
12 AstraZeneca PLC Company Profile 41
12.1 Company Overview 41
13 Baxter International Inc. Company Profile 42
13.1 Company Overview 42
13.2 Value Chain Analysis 43
13.2.1 Manufacturing 43
13.2.2 Product Development 43
13.2.3 Sales and Marketing 44
14 Boehringer Ingelheim GmbH Company Profile 45
14.1 Company Overview 45
14.2 Value Chain Analysis 46
14.2.1 Manufacturing 46
14.2.2 Product Development 47
14.2.3 Sales and Marketing 47
15 GlaxoSmithKline plc Company Profile 48
15.1 Company Overview 48
16 Novartis Medical Nutrition Company Profile 49
16.1 Company Overview 49
17 Appendix 50
17.1 Global Markets Direct Research Methodology 50
17.2 Coverage 51
17.3 Secondary Research 51
17.4 Primary Research 52
17.5 Models 52
17.6 Forecasts 53
17.7 Expert Panels 53
17.8 Currency Conversion 54
17.9 Contact Us 55
17.10 Disclaimer 55

Executive Summary

1.2 List of Figures
Figure 1: Drug Delivery Devices Cross Country Comparison (2000-2012) 18
Figure 2: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Drug Delivery Devices, Mexico, Portfolio Analysis, 2000-2012 20
Figure 4: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 21
Figure 5: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 22
Figure 6: Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2012 23
Figure 7: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2007 24
Figure 8: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2007-2012 25
Figure 9: Drug Delivery Devices, Mexico Company share (%), 2007 26
Figure 10: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 27
Figure 11: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 28
Figure 12: Infusion Systems, Mexico, Company Share (%), 2007 31
Figure 13: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 32
Figure 14: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 33
Figure 15: Inhalation Systems, Mexico, Overall Volume (Units), Historic, 2000-2007 34
Figure 16: Inhalation Systems, Mexico, Overall Volume (Units), Forecast, 2007-2012 35
Figure 17: Inhalation Systems, Mexico, Company Share (%), 2007 37
Figure 18: 3M Healthcare Value Chain Analysis 39
Figure 19: Baxter International Inc. Value Chain Analysis 43
Figure 20: Boehringer Ingelheim GmbH Value Chain Analysis 46
Figure 21: Global Markets Direct Methodology 50

3M Company
AstraZeneca PLC
Baxter International Inc
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Novartis Medical Nutrition

Customers who bought this item also bought

• Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• Medical Nutrition - A Global Market Overview
• Diabetes Diagnostics - Global Strategic Business Report
• South and Central America Drug Delivery Devices Market Outlook to 2017
• Infusion Pumps - Global Strategic Business Report
• Disinfectants - Global Strategic Business Report
• Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• Neurology Devices Market Outlook in Mexico to 2017 - Neurostimulation Devices, Interventional Neurology and Other
• Oxygen Therapy - Global Outlook